Antivirals Flashcards
why is acyclovir more selectively toxic than other antivirals?
- it is activated by viral kinases
- so you only get the drug activated in cells that are infected w/ the virus you are going after
what 3 viruses can you use acyclovir against?
VZV, HSV, EBV
what are 2 indications for valacyclovir?
- recurrent genital herpes
- zoster infections
2 indications for famciclovir?
- acute herpes zoster
- suppression of recurrent genital herpes
herpes encephalitis: early symptoms and DOC
- acute onset of fever, headache, decreased consciousness and seizures
- DOC = acyclovir
how is gancyclovir metabolized to active form inside host cell?
- acts as an antimetabolite
- first phosphorylated by viral and then by cellular kinases; then forms a nucleotide that inhibits DNS polymerase of CMV
how does cidofovir have selective toxicity?
- 1000x more effective against DNA polymerases of viruses like HSV than against DNA polymerase of host cell
what is unique about metabolism requirement of foscarnet?
- it inhibits viral DNA polymerase, RNA polymerase or HIV RT directly
- does not require activation by phosphorylation
viruses attacked by foscarnet? (7 of them)
CMV HSV VZV EBV HHV-6 HBV HIV
CDC guidelines for tx of influenze in adults
- zanamivir if 7+ yo
- aseltamivir if 1+ yo
- amatadinei for influenza A in age 1+
- rimantadine for influenza A in adults only
MOA of neurominidaze inhibitors (zanamivir and aseltamivir)
- they inhibit viral cleavage of sialic acid
- so they inhibit the release of newly formed viruses
sote of action for palivizumab
- binds to fusion (F) protein of RSV = outside the coating of the virus
- keeps the virus from attaching to and entering host cell i.e. reducing replication and spread of RSV
dosing and timing of palivizumab tx for RSV
- 15mg/kg IM monthly
- up to 5 doses during RSV season w/ 1st dose just prior to season
- kinetics: half-life = 13-27d (about the half-life of human IgG); onset w/in 48h
who should avoid contact w/ people receiving ribavirin and why?
- health care personnel (drug disperses in immediate bedside area after administration)
- prego women (teratogenic)
- adverse effects = headache, conjunctivitis, rhinitis, nausea, rash, dizziness, lacrimation, pharyngitis